Best Buy Co. (BBY) 35.39 $BBY Will Rent-A-Center's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Best Buy Co. (BBY) 35.39 $BBY

Will Rent-A-Center's (RCII) Q1 Earnings Meet Expectations? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 5:15PM CDT
Rent-A-Center (RCII) is expected to report first-quarter 2015 results on Apr 27.
RCII: 26.54 (+0.30), AEO: 17.15 (+0.05), BBY: 35.39 (-0.74), BURL: 54.35 (-0.84)

Will Big 5 (BGFV) Miss Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 5:00PM CDT
Big 5 Sporting Goods Corp. (BGFV) is scheduled to report its first-quarter fiscal 2015 results after market closes on Apr 28.
BGFV: 12.39 (-0.04), AEO: 17.15 (+0.05), DECK: 75.06 (-0.56), BBY: 35.39 (-0.74)

Look for Shares of Best Buy to Potentially Rebound after Yesterday's 2.05% Sell Off
Comtex SmarTrend(R) - Fri Apr 24, 4:01PM CDT
Best Buy (NYSE:BBY) traded in a range yesterday that spanned from a low of $35.07 to a high of $35.78. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $35.91 on volume of 7.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BBY: 35.39 (-0.74)

Watch for Best Buy to Potentially Rebound After Falling 2.05% Yesterday
Comtex SmarTrend(R) - Fri Apr 24, 4:01PM CDT
Best Buy (NYSE:BBY) traded in a range yesterday that spanned from a low of $35.07 to a high of $35.78. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $35.91 on volume of 7.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BBY: 35.39 (-0.74)

Is Whirlpool (WHR) Likely to Disappoint Earnings in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 3:11PM CDT
Whirlpool Corp. (WHR), the largest home-appliances manufacturer in the world, is slated to report its first-quarter 2015 results on Apr 28, 2015.
WHR: 196.49 (+5.57), AEO: 17.15 (+0.05), DECK: 75.06 (-0.56), BBY: 35.39 (-0.74)

Best Buy (BBY) Is Today's Roof Leaker Stock
at The Street - Fri Apr 24, 9:12AM CDT
Trade-Ideas LLC identified Best Buy (BBY) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
BBY: 35.39 (-0.74)

Best Buy (BBY) Stock Falling Today After JPMorgan Downgrade
at The Street - Fri Apr 24, 8:49AM CDT
Best Buy (BBY) stock is down after a ratings downgrade to 'neutral' from 'overweight' at JPMorgan.
BBY: 35.39 (-0.74)

Downgrade Alert for Best Buy (BBY)
Comtex SmarTrend(R) - Fri Apr 24, 7:20AM CDT
Best Buy (NYSE:BBY) was downgraded from Overweight to Neutral at JP Morgan today. The stock closed yesterday at $36.14 on volume of 4.9 million shares, above average daily volume of 4.4 million. Best Buy Co., Inc. retails consumer electronics, home office products, entertainment software, appliances and related services through its retail stores, as well as its web site. The Company also retails pre-recorded home entertainment products through retail stores.
BBY: 35.39 (-0.74)

Best Buy -2% after JPMorgan turns cautious
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 6:50AM CDT

BBY: 35.39 (-0.74)

Will Aaron's (AAN) Surprise Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 5:41PM CDT
Rent-to-own specialty retailer, Aaron's Inc. (AAN), is set to report its first-quarter 2015 earnings results on Apr 24.
AEO: 17.15 (+0.05), DECK: 75.06 (-0.56), BBY: 35.39 (-0.74), AAN: 32.80 (+3.43)

Robust Expected Growth Earns Burlington A Bullish Thesis
Equity Watch - at Seeking Alpha - Thu Apr 23, 5:38PM CDT

TJX: 66.29 (-0.04), BBY: 35.39 (-0.74), BURL: 54.35 (-0.84)

Fitch Affirms and Assigns Recovery Ratings to 3 U.S. Retail Companies' Ratings
Business Wire - Thu Apr 23, 8:23AM CDT
Fitch Ratings has affirmed and assigned the following Recovery Ratings (RRs) to U.S. Retail issuers with 'BB' category Issuer Default Ratings (IDRs):
BBY: 35.39 (-0.74)

Clearview Federal Credit Union Surprises Over 15,000 Members with Gifts and Money
PRWeb - Thu Apr 23, 6:00AM CDT
Clearview Federal Credit Union continues to surprise their members with gifts and money as part of their "Thanks a Million" initiative and 10th Anniversary Members Matter Celebration. The initiative is aimed at investing $1,000,000 in Clearview members and the Clearview community. Since January, Clearview has given over 15,000 members gifts and cash.
BBY: 35.39 (-0.74), BKS: 23.16 (+0.20)

Best Buy Award Research Shows that Singaporeans Prefer Samsung, Colgate and Magnolia
PR Newswire - Thu Apr 23, 6:00AM CDT
For residents of Singapore, products and companies such as Samsung, Colgate, Magnolia, Singtel, and Peel Fresh offer the best price-quality ratio (best value for money) in the Singaporean market.
BBY: 35.39 (-0.74)

Euro-Pro recalls 143K vacuum cleaners because of shock risk
AP - Wed Apr 22, 10:28AM CDT
NEW YORK (AP) — A Massachusetts company is recalling 143,000 upright vacuum cleaners because of the risk of electric shock.
TGT: 82.70 (+0.77), BBY: 35.39 (-0.74)

Balfour Beatty Commences Third Phase of New and Renovated Housing for Tarleton State University
Business Wire - Wed Apr 22, 8:57AM CDT
Balfour Beatty, an infrastructure group operating in construction services, infrastructure investments and support services, announced it has reached financial close on a new $76M phase of development for a comprehensive student housing project at Tarleton State University, a member of The Texas A&M University System. In this third phase of the partnership the Balfour Beatty team will deliver more than 1,000 student housing beds at the University's Stephenville, Texas campus, as well as academic space for the ROTC program and shell space for a University operated health clinic.
BBY: 35.39 (-0.74)

Will Myers Industries (MYE) Q1 Earnings Meet Expectations? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 1:59PM CDT
Myers (MYE) is expected to report first-quarter 2015 results on Apr 23.
MYE: 16.69 (-0.03), AEO: 17.15 (+0.05), BJRI: 49.52 (-3.92), BBY: 35.39 (-0.74)

The 3 Best Stocks to Invest in Electronics Retailers
Sam Mattera, The Motley Fool - Motley Fool - Tue Apr 21, 9:05AM CDT
Consumer electronics retail is a brutal business. A number of once large and dominant companies have been lost to bankruptcy, including Circuit City and, more recently, RadioShack . Investors looking for exposure don't have that many options, and...
AMZN: 445.10 (+55.11), GME: 40.71 (+0.39), BBY: 35.39 (-0.74), AAPL: 130.28 (+0.61)

Nintendo News: Get Inked! Best Buy Offers Exclusive Wii U Bundle with Splatoon on May 29
Business Wire - Tue Apr 21, 7:00AM CDT
People who can't wait to get their tentacles on Nintendo's upcoming action shooter, Splatoon, are in luck! The Wii U Special Edition Splatoon Deluxe Set launches exclusively in Best Buy stores across the country and online at BestBuy.com starting on May 29. This inkredible bundle includes a Wii U Deluxe console and both the Splatoon (via included download code) and Nintendo Land (pre-installed) games for a suggested retail price of only $299.99.
BBY: 35.39 (-0.74)

Haier 18.1 Cu. Ft. Top Mount Refrigerator Named "A Consumers Digest Best Buy"
PR Newswire - Tue Apr 21, 7:00AM CDT
Haier, the number one appliance brand in the world*, is once again being recognized in the top mount refrigerator category with a Best Buy in the April edition of Consumers Digest for the HRT18R1APW 18.1 cubic foot top mount refrigerator.
BBY: 35.39 (-0.74)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading